Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,100 | 1,015 | 98.4% |
| Education | $257.47 | 14 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,044 | 198 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,958 | 82 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,837 | 179 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,146 | 57 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,055 | 64 | $0 (2024) |
| PFIZER INC. | $939.96 | 73 | $0 (2024) |
| Abbott Laboratories | $722.82 | 29 | $0 (2024) |
| Lilly USA, LLC | $529.48 | 39 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $470.70 | 30 | $0 (2024) |
| Astellas Pharma US Inc | $450.40 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,896 | 96 | Novo Nordisk Inc ($252.22) |
| 2023 | $1,375 | 74 | PFIZER INC. ($202.55) |
| 2022 | $2,101 | 129 | GlaxoSmithKline, LLC. ($361.24) |
| 2021 | $2,303 | 150 | AstraZeneca Pharmaceuticals LP ($397.60) |
| 2020 | $2,031 | 135 | GlaxoSmithKline, LLC. ($446.92) |
| 2019 | $2,146 | 146 | AstraZeneca Pharmaceuticals LP ($492.73) |
| 2018 | $2,289 | 148 | Novo Nordisk Inc ($351.13) |
| 2017 | $2,215 | 151 | Boehringer Ingelheim Pharmaceuticals, Inc. ($250.68) |
All Payment Transactions
1,029 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Diabetes | ||||||
| 11/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.03 | General |
| 10/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: Biological | ||||||
| 10/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.47 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: NEUROLOGY | ||||||
| 09/26/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Biological | ||||||
| 09/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $9.70 | General |
| 09/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes Care | ||||||
| 09/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/28/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 5,217 | 8,047 | $1.1M | $501,325 |
| 2022 | 35 | 5,810 | 9,748 | $1.3M | $620,305 |
| 2021 | 35 | 5,784 | 9,740 | $1.3M | $581,488 |
| 2020 | 35 | 5,336 | 8,967 | $1.3M | $505,738 |
All Medicare Procedures & Services
135 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 737 | 1,703 | $366,145 | $150,037 | 41.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 582 | 582 | $136,456 | $72,593 | 53.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 293 | 1,480 | $122,840 | $65,030 | 52.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 176 | 442 | $91,936 | $40,620 | 44.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 334 | 335 | $26,800 | $24,083 | 89.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 283 | 378 | $55,944 | $22,720 | 40.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 150 | 154 | $62,062 | $20,494 | 33.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 167 | 173 | $36,849 | $15,243 | 41.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 45 | 45 | $17,100 | $12,730 | 74.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 604 | 604 | $21,744 | $10,739 | 49.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 590 | 590 | $21,240 | $10,490 | 49.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 340 | 341 | $11,594 | $10,165 | 87.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 50 | 50 | $20,500 | $7,088 | 34.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 28 | 29 | $13,978 | $5,880 | 42.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 33 | $18,282 | $5,434 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 46 | $13,294 | $4,742 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 418 | 436 | $14,824 | $4,513 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $12,675 | $3,810 | 30.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 94 | 203 | $9,338 | $3,100 | 33.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 15 | 15 | $5,010 | $1,962 | 39.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $5,206 | $1,908 | 36.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 64 | 64 | $4,160 | $1,908 | 45.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 15 | 15 | $5,895 | $1,819 | 30.9% |
| 99235 | Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes | Facility | 2023 | 11 | 11 | $3,696 | $1,353 | 36.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 15 | $2,160 | $916.35 | 42.4% |
About Dr. Deepanshu Garg, M.D
Dr. Deepanshu Garg, M.D is a Internal Medicine healthcare provider based in Goodyear, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649377813.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepanshu Garg, M.D has received a total of $16,357 in payments from pharmaceutical and medical device companies, with $1,896 received in 2024. These payments were reported across 1,029 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($16,100).
As a Medicare-enrolled provider, Garg has provided services to 22,147 Medicare beneficiaries, totaling 36,502 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 135 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Goodyear, AZ
- Active Since 09/20/2006
- Last Updated 06/19/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649377813
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,170
- Ozempic (Drug) $1,058
- XARELTO (Drug) $735.58
- ELIQUIS (Drug) $636.42
- JARDIANCE (Drug) $512.84
- FARXIGA (Drug) $475.60
- BREZTRI (Drug) $347.26
- INVOKANA (Drug) $318.94
- CHANTIX (Drug) $299.57
- STIOLTO RESPIMAT (Drug) $298.72
- Rybelsus (Drug) $286.44
- TRULICITY (Drug) $276.12
- BRILINTA (Drug) $244.03
- JANUVIA (Drug) $242.62
- ANORO ELLIPTA (Drug) $222.28
- SYMBICORT (Drug) $216.93
- ENTRESTO (Drug) $212.13
- Victoza (Drug) $198.88
- ANORO (Drug) $193.04
- Dexcom G6 Transmitter (Medical Supply) $184.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Goodyear
Paramvir Sidhu, Md, MD
Internal Medicine — Payments: $34,086
Dr. Sharad Chandrika, M.d, M.D
Internal Medicine — Payments: $14,448
Dr. Manav Jasrotia, Md, MD
Internal Medicine — Payments: $13,861
Dr. Dat Tran, M.d, M.D
Internal Medicine — Payments: $3,570
Jared Berkowitz, M.d, M.D
Internal Medicine — Payments: $2,953
Supriya Bhardwaj, Md, MD
Internal Medicine — Payments: $2,822